These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11572178)

  • 41. Cutting it close. It's the right dose and the right drug--how can it be too much?
    Karch AM; Karch FE
    Am J Nurs; 2000 Jan; 100(1):23. PubMed ID: 10705835
    [No Abstract]   [Full Text] [Related]  

  • 42. Trying to keep faith in humanity.
    Feigenbaum NL
    Pract Periodontics Aesthet Dent; 1996 Mar; 8(2):124. PubMed ID: 9028285
    [No Abstract]   [Full Text] [Related]  

  • 43. AstraZeneca reprimanded for nolvadex advertisement.
    Fintor L
    J Natl Cancer Inst; 2002 Mar; 94(5):330. PubMed ID: 11880471
    [No Abstract]   [Full Text] [Related]  

  • 44. Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence.
    Smart S; Williams C
    BMJ; 1997 Dec; 315(7122):1622-3. PubMed ID: 9437302
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of the critical event committee in a major cardiovascular outcome study.
    Heagerty A; Deverly A; Palmer C; Kaplinsky E; Salvetti A; Wahlgren NG; Funck-Brentano C
    Blood Press; 2002; 11(6):339-44. PubMed ID: 12523676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Users' guide to detecting misleading claims in research: misleading claims may be symptom of even more serious flaws.
    Penston J
    BMJ; 2005 Jan; 330(7483):145; author reply 146. PubMed ID: 15649934
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug advertising.
    Moulds RF; Wing LM
    Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
    [No Abstract]   [Full Text] [Related]  

  • 48. Misleading comparisons: the fallacy of comparing statistical significance.
    Sainani K
    PM R; 2010 Jun; 2(6):559-62. PubMed ID: 20630442
    [No Abstract]   [Full Text] [Related]  

  • 49. Nurofen advertisement was misleading, says watchdog.
    Dyer C
    BMJ; 2016 Jun; 353():i3669. PubMed ID: 27363717
    [No Abstract]   [Full Text] [Related]  

  • 50. [Conflict of interest].
    Heinzl S
    Med Monatsschr Pharm; 1998 Feb; 21(2):29. PubMed ID: 9531788
    [No Abstract]   [Full Text] [Related]  

  • 51. Letter: Assessment of advertising.
    Wigle WW
    Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
    [No Abstract]   [Full Text] [Related]  

  • 52. Statistical reporting of clinical trials with individual changes from allocated treatment.
    White IR; Pocock SJ
    Stat Med; 1996 Feb; 15(3):249-62. PubMed ID: 8643883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Misleading advertisement.
    Goldstein R
    ASHA; 1999; 41(1):6-7. PubMed ID: 9949609
    [No Abstract]   [Full Text] [Related]  

  • 54. Can drug companies have it both ways?
    Rapp MS
    CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
    [No Abstract]   [Full Text] [Related]  

  • 55. Unpublished data in drug advertisements.
    Massam D
    BMJ; 1993 Apr; 306(6885):1127. PubMed ID: 8495176
    [No Abstract]   [Full Text] [Related]  

  • 56. PAAB: a lesson in self-government.
    Lexchin J
    CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmaceutical manufacturers' compliance with drug advertisement regulations in Zimbabwe.
    Sibanda N; Gavaza P; Maponga CC; Mugore L
    Am J Health Syst Pharm; 2004 Dec; 61(24):2678-81. PubMed ID: 15646703
    [No Abstract]   [Full Text] [Related]  

  • 58. Publication of sponsored symposiums in medical journals.
    Finucane TE
    N Engl J Med; 1993 Apr; 328(16):1197; author reply 1197-8. PubMed ID: 8455691
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence based advertising? Advertisement for nifedipine does not mention admitted shortcomings of study.
    Blondeel L
    BMJ; 1997 Dec; 315(7122):1621; author reply 1621-2. PubMed ID: 9437299
    [No Abstract]   [Full Text] [Related]  

  • 60. [Doubtful advertisement on an antiepileptic agent].
    Söderfeldt B
    Lakartidningen; 2001 Mar; 98(12):1439. PubMed ID: 11320801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.